Breaking News Instant updates and real-time market news.

MCD

McDonald's

$154.82

1.675 (1.09%)

, COST

Costco

$164.34

-2.77 (-1.66%)

10:36
06/20/17
06/20
10:36
06/20/17
10:36

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Outperform from Market Perform at Cowen with analyst Andrew Charles saying value and digital are multi-year growth drivers. The firm's proprietary survey data indicates McDonald's value perceptions versus quick service peers has improved since last September when it began to market both the McPick 2 for $5 value platform and discounts only available through the app. 2. Costco (COST) upgraded to Buy from Neutral at Northcoast with analyst Chuck Cerankosky saying Costco is able to combine value merchandising with an upscale product selection in a destination shopping format, is taking market share in fresh food categories, and is shown to be relatively immune to food deflation over the past several quarters. 3. Fossil (FOSL) upgraded to Neutral from Underperform at Buckingham with the firm's analyst saying shares have pulled back below its $10 price target reaching levels not seen since the fiscal 2009 recession. 4. Goodyear Tire (GT) upgraded to Buy from Hold at Jefferies with analyst Ashik Kurian citing "improving volume momentum and strong cash returns." 5. Clovis (CLVS) upgraded to Buy from Neutral at Janney Capital with analyst Debjit Chattopadhyay citing the ARIEL3 data, which he said addressed the PARP differentiation question. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MCD

McDonald's

$154.82

1.675 (1.09%)

COST

Costco

$164.34

-2.77 (-1.66%)

FOSL

Fossil

$9.22

0.02 (0.22%)

GT

Goodyear Tire

$33.63

0.12 (0.36%)

CLVS

Clovis

$87.88

27.91 (46.54%)

  • 23

    Aug

  • 21

    Jun

MCD McDonald's
$154.82

1.675 (1.09%)

06/20/17
COWN
06/20/17
UPGRADE
COWN
Outperform
McDonald's upgraded to Outperform from Market Perform at Cowen
Cowen analyst Andrew Charles upgraded McDonald's to Outperform and raised its price target to $180 from $142 telling investors value and digital are multi-year growth drivers. The firm's proprietary survey data indicates McDonald's value perceptions versus quick service peers has improved since last September when it began to market both the McPick 2 for $5 value platform and discounts only available through the app. Value perceptions among lower income respondents positively inflected in January when it reemphasized entry-level price points. The analyst believes US sales outperformance is sustainable with its sharper focus on value promotions and digital and raised 2017 US comps to 3.4% from 2.2%, versus consensus of 2.7%, and 2018 to 3% from 2%, versus 2.5%.
06/13/17
BOFA
06/13/17
NO CHANGE
Target $175
BOFA
Buy
McDonald's price target to $175, remains a top pick at BofA/Merrill
BofA/Merrill analyst Gregory Francfort continues to view McDonald's as a top pick and sees further upside from aggressive value plans slated for early 2018 and unit economics. The analyst said McDonald's is one of the few restaurant companies that can increase franchisee economics through lower price points and can get more aggressive than peers due to higher margins. Francfort raised McDonald's price target to $175 from $165 based on FY18 earnings and reiterated his Buy rating.
06/08/17
MZHO
06/08/17
INITIATION
Target $168
MZHO
Buy
McDonald's initiated with a Buy at Mizuho
Mizuho initiated McDonald's with a Buy and a $168 price target.
06/08/17
FBCO
06/08/17
NO CHANGE
Target $165
FBCO
Outperform
McDonald's price target raised to $165 from $157 at Credit Suisse
Credit Suisse analyst Jason West raised his Q2 U.S. same-store sales growth forecast for McDonald's to 3% from 2.5% after his checks with franchisees suggested that the brand's momentum is continuing. The analyst, who keeps an Outperform rating on McDonald's shares, raised his price target on the stock to $165 from $157.
COST Costco
$164.34

-2.77 (-1.66%)

06/20/17
06/20/17
UPGRADE
Target $190

Buy
Costco upgraded to Buy, business model remains strong, says Northcoast
As previously reported, Northcoast upgraded Costco to Buy from Neutral with a $190 price target. Analyst Chuck Cerankosky said the firm's Retail Momentum Index has strengthened for Costco and expects earning to benefit from fiscal 2018 by membership fee increases that took effect on June 1. The analyst said Costco is able to combine value merchandising with an upscale product selection in a destination shopping format, is taking market share in fresh food categories, and is shown to be relatively immune to food deflation over the past several quarters.
06/20/17
NRCS
06/20/17
UPGRADE
NRCS
Buy
Costco upgraded to Buy from Neutral at Northcoast
06/19/17
06/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Costco (COST) downgraded to Hold from Buy at Deutsche Bank with analyst Paul Trussell saying positive pipeline catalysts have played out while competition is intensifying with Amazon.com (AMZN) and Wal-Mart (WMT) accelerating in-store and online efforts. The analyst lowered his price target for the shares to $172 from $187. 2. Kroger (KR) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Vincent Sinisi saying there is increased structural margin risk within the Food Retail sector following Amazon's (AMZN) acquisition of Whole Foods (WFM) and said stocks are now appropriately pricing in flat medium-term growth. 3. Wayfair (W) downgraded to Hold from Buy at Maxim with analyst Tom Forte saying he views the current share price as fully reflecting its revenue growth opportunity over the next three years and his expectation that the company can meet the top-end of its long-term adjusted EBITDA margin target of 8%-10%. 4. Travelers (TRV) downgraded to Neutral from Buy at BofA/Merrill with analyst Jay Cohen citing valuation. 5. TripAdvisor (TRIP) downgraded to Underperform from Neutral at Credit Suisse with analyst Paul Bieber citing raised expectations for TV ad spending in 2018 paired with uncertainty regarding the return on TV advertising investment given the crowded ad market for online travel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/17
RBCM
06/19/17
NO CHANGE
RBCM
Wal-Mart, Costco could be hurt by Whole Foods deal, says RBC Capital
RBC Capital analyst Scot Ciccarelli warns that Wal-Mart (WMT) and Costco (COST) could be hurt by the Whole Foods deal. The analyst says that "combining Whole Foods' high-end reputation with a logistics juggernaut like Amazon is clearly a danger" to Costco and Walmart. He thinks that Whole Foods could extend the hours in which it allows customers to buy products online and pick them up in stores, and he thinks that food delivery could become much more popular in the wake of the deal. He notes that Wal-Mart has spent a great deal of time and money on "improving its fresh and omni-channel offerings." The analyst says that Costco will be more protected due to what he sees as its "differentiated retail experience."
FOSL Fossil
$9.22

0.02 (0.22%)

03/03/17
MACQ
03/03/17
NO CHANGE
Target $12
MACQ
Underperform
Fossil price target lowered to $12 from $16 at Macquarie
Macquarie analyst Laurent Vasilescu lowered Fossil's price target to $12 from $16 and reiterated his Underperform rating following the 10K release.
03/03/17
WELS
03/03/17
NO CHANGE
WELS
Fossil has 'additional red flags,' says Wells Fargo
Wells Fargo says that Fossil's (FOSL) 10K shows that the company "is generating steep losses in the U.S." Wells adds that Adidas is terminating its partnership with Fossil nine months earlier than expected, while many of Fossil's selling prices are dropping and the sales declines of its Michael Kors (KORS) brand are accelerating. Wells says that the company's U.S. issues could cause it to violate debt covenants. Wells keeps an Underperform rating on the stock.
04/28/17
OTRG
04/28/17
NO CHANGE
OTRG
Fossil's overall sales continue to struggle, says OTR Global
OTR Global's distributor checks indicate Fossil continues to struggle with overal sales during the quarter as slowing demand for smartwatches contributed to general weakness as traditional watch sale declined.
06/20/17
BUCK
06/20/17
UPGRADE
BUCK
Neutral
Fossil upgraded to Neutral from Underperform at Buckingham
Buckingham upgraded Fossil to Neutral saying shares have pulled back below its $10 price target reaching levels not seen since the FY09 recession. The firm's analyst believes Fossil's negative thesis has played out, limiting additional near-term negative catalysts to move the stock lower from here.
GT Goodyear Tire
$33.63

0.12 (0.36%)

06/20/17
JEFF
06/20/17
UPGRADE
Target $39
JEFF
Buy
Goodyear Tire upgraded to Buy from Hold at Jefferies
Jefferies analyst Ashik Kurian upgraded Goodyear Tire to Buy citing "improving volume momentum and strong cash returns." The analyst believes expectations are bottoming and views the recent share pullback as a buying opportunity. He lowered his price target for the shares to $39 from $40.
06/15/17
DBAB
06/15/17
NO CHANGE
Target $40
DBAB
Buy
Goodyear Tire volume weaker than expected, says Deutsche Bank
Deutsche Bank analyst Rod Lache believes shares of Goodyear Tire could trade sideways until investors regain confidence in 2017 earnings. Following yesterday's updated guidance, Lache says the company's volume decline in Q2 is "much steeper than most Industry participants anticipated." He now estimates total shipments for Q2 may decline by 10%. The analyst keeps a Buy rating on Goodyear with a $40 price target.
06/01/17
06/01/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Box (BOX) upgraded to Overweight from Neutral at MUFG with analyst Stephen Bersey saying the company executed well on its strategy to increase its integration with key content providers and has a "long runway of growth ahead." 2. Skechers (SKX) upgraded to Buy from Neutral at Citi, with analyst Corinna Van der Ghinst saying after channel checks and meetings with management that she has increased confidence in the company's U.S. wholesale trajectory and new product cycle. 3. Goodyear Tire (GT) upgraded to Overweight from Underweight at Morgan Stanley with analyst Adam Jonas saying he believes tires are entering a period of secular growth as the technology revolution in mobility will drive growth in miles traveled at twice historical levels. 4. Illinois Tool Works (ITW) upgraded to Buy from Sell at Goldman Sachs with analyst Joe Ritchie double upgrading the stock and raising his price target for the shares to $155 from $131. The analyst sees upside to consensus estimates for 2017 and 2018 amid improving growth. 5. Dollar General (DG) upgraded to Accumulate from Reduce at Gordon Haskett. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/01/17
MSCO
06/01/17
UPGRADE
Target $54
MSCO
Overweight
Goodyear Tire upgraded to Overweight from Underweight at Morgan Stanley
Morgan Stanley analyst Adam Jonas upgraded Goodyear Tire two notches to Overweight from Underweight and raised its price target to $54 from $24. The analyst believes tires are entering a period of secular growth as the technology revolution in mobility will drive growth in miles traveled at 2x historical levels. The analyst sees Goodyear focusing on higher value areas of fleet service and distribution with higher competitive barriers and potentially significant financial value.
CLVS Clovis
$87.88

27.91 (46.54%)

06/20/17
FBCO
06/20/17
NO CHANGE
Target $107
FBCO
Outperform
Clovis price target raised to $107 from $88 at Credit Suisse
Credit Suisse analyst Alethia Young said she views the ARIEL3 trial data as a "major de-risking event" for Clovis that increased her conviction that Rubraca can have a meaningful market opportunity in the PARP ovarian cancer space. Young, who sees M&A and full ARIEL3 data at ESMO in September as the next important catalysts for Clovis, raised her price target on the stock to $107 from $88 and keeps an Outperform rating on the name.
06/20/17
JANY
06/20/17
UPGRADE
Target $107
JANY
Buy
Clovis upgraded to Buy 'after-the-fact' at Janney Capital
As previously reported, Janney Capital analyst Debjit Chattopadhyay upgraded Clovis (CLVS) to Buy from Neutral and raised his fair value estimate to $107 from $55 after the ARIEL3 data, which he said addressed the PARP differentiation question. In a note titled "Our Bad, We Missed the ARIEL-3 Bus. Upgrading to Buy 'After-the-Fact'," Chattopadhyay said that even after the post-data rally in Clovis shares there is still a "staggering gap" in valuation versus peer Tesaro (TSRO). Clovis, which has additional upside potential from current levels, "might be the more compelling M&A candidate," the analyst added.
06/20/17
JANY
06/20/17
NO CHANGE
Target $120
JANY
Neutral
Tesaro price target lowered to $120 from $139 at Janney Capital
Janney Capital analyst Debjit Chattopadhyay lowered his fair value estimate for Tesaro (TSRO) to $120 from $139, stating he expects competitor Clovis (CLVS) to get a broad label unencumbered by a companion diagnostic after its ARIEL3 data for its own PARP inhibitor. Given he expects AstraZeneca's (AZN) PARPi label to reflect both g+sBRCA patients, he tell investor the second-line maintenance segment will likely be "hypercompetitive" and potentially favor Astra. Chattopadhyay keeps a Neutral rating on Tesaro, but added he recognizes a buyout "in the $150 to $160 range" might be appealing to a buyer needing oncology assets.
06/20/17
JANY
06/20/17
UPGRADE
JANY
Buy
Clovis upgraded to Buy from Neutral at Janney Capital

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.